Tony Xiaobo Zhong, DrPH

Assistant Professor of Biostatistics
Icahn School of Medicine at Mount Sinai
1425 Madison Avenue, New York, NY

I grew up in Southern China. I received my education in both China and the Untied States. I speak Cantonese, Chinese Mandarin and English. I am fascinated by data science, history and sports.”

Recent Research

Statistical Methods and Software

Zhong X, Cheng B, Wang X and Cheung YK. SMARTAR: An R package for designing and analyzing sequential multiple assignment randomized trials. PeerJ Bioinformatics and Genomics, 2021

Zhong X, Cheung YK, Qian M and Cheng B. Comparing adaptive interventions under a general SMART design via multiple comparison with the best. Journal of Statistical Planning and Inference, 2020

Zhong X, Cheng B, Qian M and Cheung YK. A gate-keeping test for selecting adaptive interventions under general designs of sequential multiple assignment randomized trials. Contemporary Clinical Trials, 2019

Designer and developer of R statistical software package: SMARTAR – Sequential Multiple Assignment Randomized Trial with Adaptive Randomization (Available to download at: https://cran.r-project.org/web/packages/SMARTAR/index.html)

Health Economics and Outcome Research (HEOR)

Zhong X, Zhou Z, Li G, Kwizera MH, Muennig P and Chen Q. Neigborhood disparities in COVID-19  outcomes in New York City over the first two waves of the outbreak. Annuals of Epidemiology, 2022

Zhong X and Hao Q. Are women underrepresented in cerebrovascular disease clinical trials? A systematic review of clinical trials in 2002-2017 using the FDA database. Journal of Clinical Trials, 2021

Zhong X, Lin J, Barret AM, Poeran J and Mazumdar M. Derivation and validation of a novel comorbidity-based delirium risk index to predict postoperative delirium using national administrative health database. Health Services Research. 2020

Cancer Epidemiology

Shah NJ, Patel VG, Zhong X, Pina L, et al., Oh WK. The impact of androgen deprivation therapy on COVID-19 illness in men with prostate cancer. JNCI Cancer Spectrum, 2022

Bikkasani K*, Qin Q*, Zhong X, Lin J, Galsky M, Oh MK, and Tsao CK. Characterizing prostate specific antigen levels at death in patinets with metastatic castration resistant prostate cancer: are we underutilizing imaging? Clinical Genitourinary Cancer, 2021

Tharakan S, Zhong X and Galsky M. The impact of globalization of cancer clinical trials on enrollment of black patients. Cancer, 2020 

Anish P,  Zhong X, Mellgard G, Qin Q, Patel V, Wang B, Alerasool P, Garcia P, Leiter A, Gallagher E and et al. Risk factors for emergency room and hospital care among patients with solid tumors on immune checkpoint inhibitor therapy. American Journal of Clinical Oncology, 2020

Other Collaborations

Kumar RG, Zhong X, Whiteneck GG, Mazumdar M, et al., Christen Dams-O’Conner. Development and validation of a functionally relevant comorbidity health index in adults admitted to inpatient rehabilitation for traumatic brain injury. Journal of Neurotrauma, 2022

Mazumdar M, Zhong X and Ferket B. Principles and Practice of Clinical Trials. Chapter 6: Diagnostic Trials. Springer, Swizerland, 2021

Wang AL, Zhong X and Hurd Y. Comorbidity and sociodemographic determinants in COVID-19 mortality in an US urban healthcare system. MedRxiv, 2020